Tirupati Starch & Chemicals Ltd
- Market Cap ₹ 108 Cr.
- Current Price ₹ 112
- High / Low ₹ 195 / 106
- Stock P/E
- Book Value ₹ 64.4
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 10.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 9.46% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59 | 158 | 177 | 199 | 227 | 271 | 200 | 318 | 364 | 306 | 386 | 363 | 359 | |
| Sales growth | -3% | +167% | +12% | +13% | +14% | +19% | -26% | +59% | -16% | +26% | -6% | -5% | |
| 55 | 152 | 169 | 189 | 216 | 263 | 191 | 298 | 343 | 285 | 361 | 338 | 340 | |
| Operating Profit | 4 | 6 | 8 | 10 | 11 | 8 | 9 | 19 | 21 | 21 | 25 | 25 | 18 |
| OPM % | 6% | 3.5% | 4.3% | 5% | 4.8% | 3.0% | 4.6% | 6% | 6% | 7% | 6% | 7% | 5% |
| 1 | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 4 | 3 | 2 | |
| Interest | 1 | 6 | 5 | 4 | 3 | 2 | 3 | 6 | 8 | 10 | 11 | 10 | 9 |
| Depreciation | 2 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 8 | 8 | 10 |
| Profit before tax | 1 | -5 | 0 | 2 | 4 | 2 | 1 | 9 | 8 | 3 | 10 | 9 | 2 |
| Tax % | 193% | -67% | -3,700% | 21% | 21% | 26% | 4% | 12% | 14% | 31% | 26% | 27% | |
| -1 | -2 | 1 | 2 | 3 | 1 | 1 | 8 | 7 | 2 | 8 | 6 | -0 | |
| EPS in Rs | -1.95 | -2.48 | 1.87 | 2.90 | 5.32 | 1.89 | 1.47 | 11.80 | 8.12 | 2.28 | 7.85 | 6.74 | -0.34 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 0% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -1% |
| TTM: | -103% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 18% |
| 3 Years: | -2% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 10 | 10 | 10 | 10 |
| Reserves | 6 | 4 | 7 | 11 | 15 | 16 | 21 | 29 | 38 | 44 | 51 | 58 | 52 |
| 44 | 54 | 49 | 26 | 23 | 22 | 55 | 77 | 90 | 154 | 136 | 110 | 101 | |
| 27 | 40 | 44 | 65 | 94 | 96 | 51 | 45 | 33 | 19 | 34 | 33 | 42 | |
| Total Liabilities | 82 | 105 | 107 | 109 | 138 | 140 | 133 | 158 | 169 | 227 | 230 | 210 | 205 |
| 61 | 59 | 64 | 65 | 60 | 55 | 71 | 61 | 55 | 93 | 98 | 134 | 120 | |
| CWIP | 0 | 4 | 0 | 0 | 9 | 18 | 7 | 16 | 46 | 27 | 40 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 21 | 43 | 42 | 44 | 69 | 66 | 55 | 80 | 68 | 107 | 92 | 76 | 85 | |
| Total Assets | 82 | 105 | 107 | 109 | 138 | 140 | 133 | 158 | 169 | 227 | 230 | 210 | 205 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | -4 | 14 | 33 | 5 | 12 | -35 | -1 | 23 | -34 | 49 | 42 | |
| -20 | -6 | -5 | -5 | -9 | -9 | -6 | -6 | -25 | -32 | -26 | -7 | |
| 3 | 10 | -8 | -28 | 4 | -3 | 41 | 7 | 9 | 59 | -24 | -35 | |
| Net Cash Flow | 0 | -0 | -0 | 0 | 0 | -0 | -0 | -0 | 8 | -7 | -1 | -0 |
| Free Cash Flow | -6 | -11 | 8 | 28 | -4 | 3 | -41 | -6 | -3 | -65 | 22 | 35 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 466% | -76% | 179% | 330% | 56% | 138% | -372% | 4% | 116% | -159% | 198% | 174% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
Consolidated / View Standalone
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 44 | 36 | 38 | 61 | 37 | 45 | 35 | 33 | 41 | 37 | 30 |
| Inventory Days | 112 | 55 | 43 | 33 | 41 | 48 | 39 | 54 | 19 | 83 | 54 | 50 |
| Days Payable | 223 | 89 | 58 | 54 | 99 | 154 | 90 | 55 | 30 | 13 | 24 | 28 |
| Cash Conversion Cycle | -66 | 10 | 20 | 17 | 2 | -69 | -6 | 33 | 22 | 111 | 68 | 53 |
| Working Capital Days | -118 | -24 | 10 | 6 | 14 | -51 | 0 | 21 | -2 | 23 | -5 | -12 |
| ROCE % | 5% | 3% | 6% | 12% | 15% | 9% | 7% | 16% | 8% | 10% | 10% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Starch and Dextrose products revenue share % of total revenue ・Standalone data |
|
|||||||||||
| Permanent employee count employees ・Standalone data |
||||||||||||
| Bank limit utilization % ・Standalone data |
||||||||||||
| Maize milling capacity TPD ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Submission of Newspaper Advertisement published for the extract of unaudited standalone & Consolidated Financial Results for the quarter & half year ended on 30.09.2026
-
Results - Financial Results For 30-09-2026
- Approved unaudited Q2 and half-year FY2026 results; auditor noted ₹158.43 lakh income tax demand.
-
Board Meeting Outcome for Outcome Of Board Meeting Of Company (Meeting No.: BM/06/2026-27) Held On 14Th November, 2026
- Board approved standalone and consolidated results for quarter and half year ended 30 September 2026.
-
Intimation Of Execution Of Agreement For Sale Of Immovable Property, Pursuant To Regulation 30 Of The SEBI (LODR) Regulation, 2015
- Company executed agreement to sell Indore property for Rs. 2.98 crore on 7 Nov 2026.
-
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015
- Board meets on 14 Nov 2026 to approve Q2 and half-year FY2026-27 unaudited results.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Product Profile:[1][2]
a) Main Products:
Maize Starch Powder, Dextrose Anhydrous, Dextrose Monohydrate, Dextrin (White & Yellow), IP Starch, Liquid Glucose, Tyrolese, Vervosize
b) By Products:
Hydrol, Maize Bran, Maize Cattle Feed, Grit, Maize Germ, Maize Gluten, Maize Husk Dry/ Wet, Corn Gluten, and Corn Gem